Recently added articles from BIOTECH Patent News:
Hospital Approved Residential Water Features Kill Harmful Airborne Bacteria.(Accents In Water is a division of Kloppenberg and Co.)
Apr 01, 2009 ... It first began as an idea to fight airborne germs and bacteria in hospitals and healthcare settings, and in fact, Accents in Water (Denver, CO) remains the only Hospital-Approved, clinically tested water features available in the world today. Then, general public settings like restaurants, ...
Star Scientific Reports on Filing Patent Application for Zero-Nitrosamine Tobacco Curing Process, Product Development by Rock Creek Pharmaceuticals.
Apr 01, 2009 ... Star Scientific (Petersburg, VA) and its wholly-owned subsidiary, Rock Creek Pharmaceuticals, reported on their continuing efforts to lessen the harm linked with tobacco use. Star Scientific, through its CEO Jonnie R. Williams, recently filed a new US Patent Application for a novel ...
GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company.(Company overview)
Apr 01, 2009 ... GlaxoSmithKline plc (London, United Kingdom) and Pfizer, Inc (New York, NY) announced they have entered into an agreement to create a new world-leading HIV company focused solely on research, development and commercialisation of HIV medicines. The new HIV business will be more sustainable ...
Rib-X Granted Key Antibiotic Patent in China.
Apr 01, 2009 ... Rib-X Pharmaceuticals, Inc. (New Haven, CT), a development-stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic-resistant infections, announced the issuance of a key antibiotic patent in China. The State Intellectual Property Office of ...
Prometheus and Rosetta Genomics Announce License and Collaboration Agreement.
Apr 01, 2009 ... Prometheus Laboratories Inc. (San Diego, CA), a specialty pharmaceutical and diagnostic company, and Rosetta Genomics Ltd. (Rehovot, Israel), an innovative molecular diagnostic company, announced the execution of a license and collaboration agreement under which Rosetta shall grant ...
Sinobiopharma Applies for Chinese Patent to Develop the Next Generation of Anti-Hypertension Compounds.(Company overview)
Apr 01, 2009 ... Sinobiopharma, Inc. (Nanjing, China) has applied for a single Chinese patent for new drug compounds containing Perindopril, an angiotensin-converting enzyme (ACE) inhibitor used to treat high blood pressure (hypertension) and heart attack in people with coronary artery disease ....
Medical International Announces that it has received a US Patent for its Needle-Free Jet-Injector.
Apr 01, 2009 ... Medical International Technology, Inc. (Denver, CO) has obtained another US patent from the United States Patent and Trademark Office for its Needle-Free Jet-Injector. Other similar international patents are pending. MIT is pleased to obtain this patent for it will help the company enter ...
Shire Files Lawsuit Against Natco Pharma for Infringement of FOSRENOL (lanthanum carbonate) Patents.
Apr 01, 2009 ... Shire plc (Philadelphia, PA) has filed a lawsuit in the United States District Court for the Southern District of New York against Natco Pharma Limited for infringement of two of Shire's patents: United States Patent 5,968,976; and United States Patent 7,381,428. The lawsuit was ...
Affitech Strengthens Patent Position on its Phagemid Antibody Screening Technology in Europe.
Apr 01, 2009 ... The human antibody company, Affitech AS (Oslo, Norway) announced that the European Patent Office has granted an European patent on the use of phagemid particles having an antibody-coliphage pIII fusion protein, to identify tumor associated antigens on cells by negative selection. The new ...
Nuevolution Announces Progress in its Collaboration With Merck.
Apr 01, 2009 ... Nuevolution A/S (Copenhagen, Denmark) announced that Merck & Co., Inc. has chosen to proceed to the second phase of the collaboration agreement announced in June 2008 to apply Nuevolution's proprietary Chemetics drug discovery technology to identify novel small molecule leads against ...
Japan Tobacco obtains United States patent.
Apr 01, 2009 ... Japan Tobacco, Inc. (Tokyo, Japan) has patented disease-resistant plants which have been transformed to cause an effective defense reaction, and methods for producing the same.The present invention provides expression ...
Rockefeller University obtains United States patent.
Apr 01, 2009 ... Rockefeller University (New York, NY) has patented chemically inducible promoters that may be used to transform plants, including tobacco and lettuce, with genes which are easily regulatable by adding the plants or plant cells to a medium containing an inducer of the promoter or by ...
University of Kentucky obtains United States patent.
Apr 01, 2009 ... University of Kentucky (Lexington, KY) has patented novel isolated nucleic acids encoding antigenic proteins derived from Sarcocystis neurona, or unique fragments thereof. In particular, the invention provides novel isolated nucleic acids encoding membrane-associated polypeptides SnSAG2, ...
National Research Council of Canada obtains United States patent.
Apr 01, 2009 ... National Research Council of Canada (Ottawa, Canada) has patented nucleotide sequences commonly designated CJAS1 comprising a novel gene from plants. The novel gene encodes a protein that is involved in seed formation and is associated with plant defense. The invention further relates to ...
Amgen obtains United States patent.
Apr 01, 2009 ... Amgen, Inc. (Thousand Oaks, CA) has patented methods and compositions for treating excess weight by administering OB protein in a form for constant supply, at a dosage of less than or equal to about 1 mg protein/kg body weight/day. Compositions and methods used for production of ...
Matsumoto obtains United States patent.
Apr 01, 2009 ... Matsumoto (Hirano-ku, Osaka-shi, Japan) has patented a novel carboxypeptidase and the encoding gene thereof were successfully identified by screening a human hippocampus extract using brain-APP-cleaving activity as an index. Antibodies ...
Yeda Research and Development obtains United States patent.
Apr 01, 2009 ... Yeda Research and Development Co., Ltd. (Rehovot, Israel) has patented proteins IR1B1 and IR1B4 which have been isolated and which bind to the type I IFN receptor IFNAR1 and function in the cellular response to IFNs. DNA encoding such proteins ...
University of Pennsylvania obtains United States patent.
Apr 01, 2009 ... University of Pennsylvania (Philadelphia, PA) has patented replication competent variants of mammalian immunodeficiency virus comprising mutations and/or deletions of the V3 hypervariable loop and compensatory mutations, as well as methods for producing such variants. The invention also ...
Washington State University obtains United States patent.
Apr 01, 2009 ... Washington State University (Pullman, WA) has patented novel protein interaction reporter (PIR) compounds (e.g., formulas I and II), comprising at least two protein reactive moieties (e.g., N-hydroxysuccinamide), each linked to a reporter moiety (e.g., mass reporter) by a covalent labile ...
McMaster University obtains United States patent.
Apr 01, 2009 ... McMaster University and Hamilton Health Sciences Corporation (Hamilton, Canada) has patented methods for preventing the generation of active thrombin on the surface of cells. The present methods are based upon the surprising discovery that expression or activation ...
